Werkgroep Cardiologische centra Nederland English

Stability LPL II (Afgerond)

A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Middel
darapladib
Populatie
ASCVD
Fase
III
Jaar aanvang
2009
Meer informatie
ClinivalTrials.gov

Studiedirecteur

drs. H.P. Swart (Cardioloog)
Sneek, D&A Research and Genetics

Stability LPL II: Nieuws